It might sound crazy; but yes. It’s possible to reverse aging by transfusing the blood of teenagers into older adults. Though this idea seems to be haunting everyone’s mind, it finally got implemented by a startup company named Ambrosia in California. Ambrosia conducted human trials, where every 1.5 liters young plasma transfusion would cost around $8000 to the participants. This human trial was completed on Jan 15, 2018, with noteworthy results.

Anti-aging studies are still going on worldwide, in spite of having lots of good and bad consequences. During the 1950’s, scientists proved that the organs of older mice became healthier, by injecting them with younger blood. The scientists also found that aging was connected to only body and it’s ultimately the blood which directs aging.

Tony Wyss-Coray from Stanford University criticized the study of Ambrosia since they charged the participants. Keeping that in mind, he led the anti-aging study in 2014 with his company Alkahest to detect the effect of young blood on Alzheimer patients free of cost. In the U.S. alone, the anti-aging industry is worth around $250 billion and hence it is sure that many private businesses would surely show their interest in this research.